Biophysium, in partnership with LaPEC, will start in October 2024 a new innovative thesis which will focus on the assessment of cardiac remodelling using innovative echocardiographic approaches based on three-dimensional myocardial analyses with the aim of studying the link between flow, morphology and left ventricular function in a pathophysiological continuum of cardiac remodelling.
Biophysium is in the process of finalising the recruitment of a candidate to carry out this thesis.

This approach will enable Biophysium to renew its position as leader in medical AI, and help practitioners to diagnose cardiac pathologies for better management.